Eur J Haematol 2004, 72:314–321 PubMedCrossRef 23 Pechandova K,

Eur J Haematol 2004, 72:314–321.PubMedCrossRef 23. Pechandova K, Buzkova H, Slanar O, Perlik F: Polymorphisms of the MDR1 gene in the Czech population. Folia Biol (Praha) 2006, 52:184–189. 24. Landgren O, Caporaso NE: New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin’s lymphoma. Hematol Oncol Clin North Am 2007, 21:825–840.PubMedCrossRef 25. Turgut S, Yaren A, Kursunluoglu R, Turgut G: MDR1 C3435T polymorphism in patients with breast cancer. Arch Med Res 2007, 38:539–544.PubMedCrossRef

26. Siegsmund M, Brinkmann U, Schaffeler E, Weirich G, Schwab M, Eichelbaum M, Fritz P, Burk O, Decker this website J, Alken P, Rothenpieler U, Kerb R, Hoffmeyer S, Brauch H: Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 2002, 13:1847–1854.PubMedCrossRef 27. Tatari F, Salek R, Mosaffa F, Khedri A, Behravan J: Association of C3435T single-nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian population. DNA Cell Biol 2009, 28:259–263.PubMedCrossRef 28. Kaya P, Gunduz U, Arpaci F, Ural AU, Guran S: Identification of polymorphisms on the MDR1 gene among selleck screening library Turkish population and their effects on multidrug resistance in acute leukemia patients. Am J Hematol 2005, 80:26–34.PubMedCrossRef 29. Urayama KY, Wiencke JK,

SIS3 order Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL: MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomark Prev 2007, 16:1172–1177.CrossRef 30. Humeny A, Rödel F, Rödel C, Sauer R, Füzesi L, Becker C, Efferth T: MDR1 single nucleotide polymorphism C3435T in normal colorectal tissue and colorectal

carcinomas detected by MALDI-TOF mass spectrometry. Anticancer Res 2003, 23:2735–40.PubMed 31. Larsen AK, Escargueil AE, Skladanowski A: Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000, 85:217–229.PubMedCrossRef 32. Pan JH, Han JX, Wu JM, Huang HN, Yu QZ, Sheng LJ: MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin check details chemotherapy in patients with non-small-cell lung cancer. Respiration 2009, 78:49–55.PubMedCrossRef 33. Pan JH, Han JX, Wu JM, Sheng LJ, Huang HN, Yu QZ: MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer. Respiration 2008, 75:380–385.PubMedCrossRef 34. Sohn JW, Lee SY, Lee SJ, Kim EJ, Cha SI, Kim CH, Lee JT, Jung TH, Park JY: MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer. Jpn J Clin Oncol 2006, 36:137–141.PubMedCrossRef 35.

Comments are closed.